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Abstract
Background: Measles is a highly contagious viral infection causing large outbreaks all over the world. Despite the
availability of safe and cost effective vaccine, measles remained endemic with persistent periodic outbreaks in the
Horn of Africa. The aim of this study is to characterize laboratory confirmed measles cases in Amhara Regional
State, which was one of the highly affected regions in Ethiopia.
Method: A suspected measles case was defined as any person presenting with fever, maculopapular rash and one
or more of the three symptoms cough, coryza or conjunctivitis or a patient in whom a clinician suspects measles. A
blood sample was collected for any measles suspected patient with a case based investigation form and specimen
transported to the National Measles Laboratory in good condition where it was to be tested for Measles IgM
antibody by ELISA technique. Data was entered and analyzed using Epi-Info 3.5.4 software.
Result: A total of 6579 samples were tested for measles IgM among 7296 samples collected in Amhara Regional
State over 11 years (2004–2014). Of the tested samples, 2412 (36.7 %) were found positive, while 3965 and 202
samples were found to be negative and equivocal (compatible) respectively. Patients with age ≥10 years were the
most affected. The highest number of laboratory confirmed measles cases were detected in 2014 and cases were
occurred in all of the 11 zones of the state. A seasonal peak was noted in the hot-dry season of the year.
Conclusion: Measles remains to be a public health problem in Amhara Regional State of Ethiopia, mostly affecting
people ≥10 years of age. Measles virus was detected in all zones of the state, reaching its peak in the hot-dry
season. To reduce the incidence of measles, it is highly recommended to improve routine immunization, and
conduct a wide age group campaign.
Additional research to evaluate the knowledge, attitudes and practices of the general population and health care
professionals about measles infection and vaccination is important. Genotyping of circulating measles virus strain is
recommended.
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Background
Measles is one of the most contagious vaccine preventable
viral diseases and is known to cause severe complications
such as encephalitis, pneumonia, ear and sinus infections,
persistent diarrhea, upper airway obstruction, mouth ulcers
and death. It is caused by the genus Morbillivirus within
the family Paramyxovirus for which humans are the only
reservoir [1]. Transmission is primarily person-to-person
via aerosolized droplets or by direct contact with the nasal
and throat secretions of infected persons. Measles out-
breaks occur when the number of susceptible individuals in
the population reaches a critical threshold due to low vac-
cination coverage and high prevalence of malnutrition [2].
Globally, an estimated 197,000 measles deaths occurred
in 2007, with 136,000 (69 %) and 45,000 (23 %) occurring
in Southeast Asia and Africa respectively. Generally in
Africa, the measles case fatality rate ranges from 3 to 5 %,
reaching up to 30 % during severe outbreaks and outbreaks
in closed communities such as refugee camps [3]. Measles
continues to be a major public health problem in Africa,
causing an estimated 28,000 deaths each year [4].
Following the initiation of accelerated measles control,
Ethiopia has conducted a series of emergency and catch-
up measles immunization campaigns between 2002
and 2004 which were conducted in a phased manner
throughout the country, with average national coverage
of 92 %. Measles case based surveillance, including la-
boratory confirmation, was initiated in 2004 to enhance
detection, investigation and control of outbreaks. Since
2005 sub-national level follow-up SIAs have been carried
out in an interval of 2–4 years [5, 6].
Among others the case-based surveillance for mea-
sles requires that all suspected measles cases are
investigated during initial contact with the case using
an individual case investigation form; a blood specimen is
collected for serologic confirmation of measles infection.
The laboratory plays a central role in the confirmation of
suspected cases and outbreaks, and in the identification of
circulating strains of measles virus [2].
The WHO African measles elimination goals aim at im-
proving case based surveillance and achieving and sustain-
ing high measles vaccination coverage to reduce measles
incidence < 1 confirmed cases per million by 2020 in the
African region including Ethiopia [2]. But in recent years,
persistent and recurrent measles outbreaks have occurred
in several areas of Ethiopia including Amhara Regional
State and more than 14,000 confirmed measles cases were
reported in Ethiopia during 2014 [7–9]. The purpose of this
report is to characterize the epidemiology of laboratory-
confirmed measles cases in the Amhara Regional State of
Ethiopia and to provide evidence for the decision making
process in an effort to eliminate measles in Ethiopia.
Methods
Study setting
The study was conducted in the Amhara Regional State,
the second most populous region in Ethiopia with a popu-
lation of 17.22 million [10]. The region covers an area of
154,709 km2 and is located in the North Western and
North central part of Ethiopia. The State shares common
borders with Tigray, Afar, Oromia and Benshangul Gumuz
regional states in North, East, South and South-West re-
spectively and the Republic of South Sudan in the west.
Administratively the region is divided into 11 zones and
further sub-divided into woredas and kebeles (Fig. 1).
Fig. 1 Map of Ethiopia Showing the Relative Location of Amhara Regional State and its Administrative Zones (Source, WIKIPEDIA, the
Free Encyclopedia)
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Study population and case definitions
National guidelines for measles surveillance are based on
the WHO/-AFRO Measles and Rubella Surveillance guide-
line, and define a suspected measles case as any person
with a generalized maculopapular rash and fever plus one or
more of the following: 1) cough, 2) coryza), or 3) conjunc-
tivitis OR any person in whom a clinician suspects measles.
A case of laboratory confirmed measles is a suspected mea-
sles case that is investigated (including the collection of
blood specimen), and has serological confirmation of recent
measles virus infection (presence of measles IgM antibody)
who has not received measles vaccination in the 30 days
preceding the specimen collection. Measles confirmed by
epidemiological linkage is a suspected measles case that has
not had a specimen taken for serologic confirmation and is
linked (in place, person and time) to a lab confirmed cases.
A clinically confirmed/compatible measles case is defined
as a suspected measles case that has not had a blood speci-
men taken for serologic confirmation and is not linked
epidemiologically to any lab confirmed outbreak of measles.
A confirmed outbreak of measles is defined as 3 or more
laboratory confirmed cases of measles in a health facility or
district in a one month period [2].
All patients regardless of age and sex that fulfilled the
case definition for measles during the study period
(2004–2014) were included in this analysis.
Specimen collection and transportation
Between 1 January 2004 and 31 December 2014, blood
samples were collected from suspect measles cases in all
zones of Amhara Regional State and transported to the
National Measles Laboratory, located at the Ethiopian
Public Health Institute (EPHI) in Addis Ababa for labora-
tory confirmation. Samples were collected and transported
in good laboratory condition (adequate volume, no leak-
age, not turbid from possible contamination, not desic-
cated and container temperature of 2–8°c). Demographic
and clinical information about the patient was captured
through the case based investigation form.
Laboratory method and quality assurance
Samples were tested for measles virus specific IgM antibody
by indirect enzyme linked immuno-sorbent assay (ELISA)
using a commercially available test kit (Siemens Healthcare
Diagnostics Products GmbH, Marburg, Germany). Stand-
ard operational procedures (SOPs), and job aids are avail-
able for the laboratory activities. All the instruments and
materials of the laboratory were supplied by WHO.
The Ethiopian National Measles Laboratory is a mem-
ber of the global WHO vaccine-preventable disease
laboratory network and works according to WHO stan-
dards and protocols, receives external quality assessment
(EQA) panel samples annually, sends 10 % quality con-
trol (QC) samples to regional reference laboratory (RRL)
quarterly and is accredited annually. The laboratory also
applied external (kit) and internal (in house) control
samples in each run and results were reported only
when the run was valid based on the controls. The
national laboratory scored ≥95 % performance for both
EQA and QC during this study period.
Data analysis and ethical consideration
The laboratory test result and demographic information
provided on the case investigation form were entered
into the measles case-based surveillance system data-
base. Data were consolidated, cleaned, analyzed and
disseminated to stake holders for action using Epi-
Info software version 3.5.4. Demographic characteris-
tics of reported cases and trends in cases reported
over time were assessed. The study was ethically approved
by institutional review board of EPHI.
Results
Between 01 January 2004 and 31st December 2014, 7296
suspected measles cases investigated had both case report
forms and blood samples available through the case-based
surveillance system. Of these cases, 3781 (51.2 %) were
males. The information on gender was unavailable for 17
cases. The mean age of suspected cases was 9.7 years, ran-
ging from a month to 68 years (SD = ±8.8 years).
Measles was detected in all 11 zonal administrations with
the lowest number of cases (75) and positivity rate (3.1 %)
in Bahir Dar special zone. Higher number of cases and
positivity rate were noted in North Gonder (394, 16.3 %)
and South Wello (392, 16.3 %) zones (Table 1). The
suspected cases increased from 123 in 2004 to 1107 in
2014 (Fig. 2). Measles cases were reported throughout the
year with peaks in February (294) and March (348) and the
lower number (100) of cases reported in August (Fig. 3).
Of the 7296 suspected cases, 6579 (90 %) samples
were tested by the laboratory for measles virus specific
IgM antibody. Of these 2412 (36.7 %) were IgM positive
(laboratory confirmed measles): 3965 cases were nega-
tive for the presence of measles IgM antibody and 202
specimens had equivocal lab results.
Among 2412 lab confirmed measles, 1251 (51.9 %)
were males and 9 cases had no information on sex avail-
able on the case report. The number of lab confirmed
measles cases increased from 7 cases in 2004 to 611 in
2014 (Fig. 2). 1160 (48 %) of all lab-confirmed measles
cases were in individuals ≥ 15 years of age (Fig. 4).
During the study period, the total number of clinically
compatible cases was 9699. The percent and number of
clinically confirmed/compatible cases fluctuated by year
but reached its peak (35 %, 5237) in 2014. The propor-
tion of discarded cases (measles IgM negatives) de-
creased dramatically from 70 % in 2004 to 12 % in 2014.
23,842 epidemiologically-linked (Epi-linked) cases were
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reported between 2004 and 2014. The number of Epi-
linked cases reached its peak in 2014 at 5701 (Fig. 5).
Discussion
The African region has set a goal to eliminate measles
infection by 2020. This would require achieving a measles
incidence of less than one confirmed measles case
reported per million population per year. High measles
vaccination coverage (95 % nationally and at district level),
and a non-measles febrile rash (measles IgM negative or
discarded case) rate of at least 2 per 100,000 population at
national level indicating a high surveillance performance
are two of the strategies needed to achieve this goal [2].
Although there is variability among zones, the Amhara
Region State met the targets for these two principal mea-
sles surveillance performance indicators.
From January 2004 through December 2014, a total of
2412 laboratory confirmed measles cases were found
from all the 11 zones of Amhara Regional State,
Ethiopia. A total of 717 samples were not tested during
2009–2011 and in 2014 due to shortage of measles kit.
During this same time period, 23,842 cases were classi-
fied as epidemiologically linked and an additional 9699
cases were defined as clinically compatible.
In general, the laboratory confirmed, clinically confirmed
and epi-linked measles cases increased in the study period.
The number and percentage of laboratory confirmed mea-
sles cases increased from 7 (5.7 %) in 2004 to 611 (65.9 %)
in 2014 despite an increasing report of administrative mea-
sles vaccination coverage [11]. In the consistent laboratory
testing system, the dramatic increase is likely due to a var-
iety of factors including an increased pool of susceptibles
due to long-standing sub-optimal vaccination coverage.
The circulation of measles virus was affirmed by the pres-
ence of many confirmed outbreaks in the region [7, 8, 12].
The other contributing factor might be the improved
surveillance system in terms of coverage, quality, and sensi-
tivity due to massive health service expansion through time
in the country as well in the region [13]. This finding was
similar to the findings in Nigeria and Germany [3, 14].
We also noted a fluctuation of laboratory confirmed
measles cases in the study years, high incidence of cases
following a low incidence period detected in the area. This
was a similar finding to a study in South West Nigeria [3],
typical of measles epidemiology. Additionally, the interval
Fig. 2 Trend of Measles Suspected, Laboratory Tested and Confirmed Cases by Year of Disease Onset in Amhara Regional State of Ethiopia, 2004–2014
Table 1 Distribution of confirmed measles cases by selected
demographic characteristics of patients, Amhara Regional State,
Ethiopia, 2004–2014








Zones N = 2412
Awi 122 5.1 %
Bahir Dar 75 3.1 %
East Gojjam 240 10.0 %
North Gonder 394 16.3 %
North Shewa 381 15.8 %
North Wello 164 6.8 %
Oromiya 103 4.3 %
South Gonder 241 10.0 %
South Wello 392 16.3 %
West Gojjam 221 9.2 %
Wag Himra 79 3.3 %
Age Group (Years) N = 2412
<1 91 3.8 %
1–4 429 17.8 %
5–9 348 14.4 %
10–14 366 15.2 %
= > 15 1160 48.1 %
Missing 18 0.7 %
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and coverage of SIAs [15] conducted might have contrib-
uted to the fluctuation.
It was revealed from the result that there were a lower
number of lab confirmed cases in 2009 relative to 2008
and 2010. This might be related to the high measles vac-
cination coverage (96 %) achieve during the SIA in the
regional state during 2008 [16]. This finding was similar
to the findings in Nigeria and Germany [3, 14] and
reinforce the theory that measles is one of the first dis-
eases to re-emerge when vaccination coverage falls [17].
With high coverage of routine measles vaccination,
outbreaks are expected to stop altogether and transmis-
sion interrupted. However, in this region outbreaks did
not stop and transmission was not interrupted despite
increasing vaccination coverage reported in routine
immunization and SIAs [15]. There were consistently
increasing measles outbreaks like in South Gonder zone
Simada district [12] and massive case reporting contin-
ued with increasing number of laboratory confirmed
cases (Figs. 2, 4 and 5).
In this study, there was a gradual increase in the number
of laboratory confirmed measles cases and persistent high
measles positivity rate among patients ≥10 years age group
and a decrease of cases among children under one year.
This may reflect low immunization coverage in the region
in previous years, and as a result more susceptibles accu-
mulated in these age groups, which created a favorable
condition for measles outbreaks to occur and measles to
circulate in these age groups. On the other hand the lower
positivity rate among <1 year children may indicate the
improvement of routine immunization. This higher
measles positivity rate among adults was similar finding
with studies in South Africa [18] and Europe [19].
Measles infection in adults may have serious conse-
quences for children. Infected adults will be unable to
work and care for their children and will transmit the
virus to their susceptible children [20] as measles is
highly communicable, with secondary attack rates greater
than 90 % among susceptible persons [1]. Although



















YEARS OF MEASLES ONSET
Fig. 3 Distribution of Laboratory Confirmed Measles cases by Year and Month of disease onset in Amhara Regional State of Ethiopia, 2004–2014
Fig. 4 Trend of Measles Confirmed cases (%) by Age Group of Patients and Years in Amhara Regional State of Ethiopia, 2004–2014
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were not captured in our database, there likely were
deaths and complications that occurred in Amhara Re-
gional State of Ethiopia during the study period as illus-
trated by other studies [11, 12].
In addition, our study revealed seasonality of measles
confirmed cases during the period of analysis (2004–
2014), with higher number of cases during February–
March (hot dry season) and lower numbers in the rainy
season of the region (July-September). This might be re-
lated with the population movement and many trad-
itional ceremonies (wedding, religious festivals) during
this season that created a favorable condition for mea-
sles transmission. Seasonal variation in the hot dry sea-
son was also noted in a study finding in Nigeria [3].
The analysis also indicated that a high proportion (60 %)
of suspected measles cases reported and tested in this sur-
veillance system had negative results for measles IgM
throughout the study years. This high IgM negativity rate
may be a good sign for the laboratory surveillance system.
Measles cases (suspected, confirmed) and outbreaks
are increasing from year to year in the region. However,
still there is no genotype data available to map circulat-
ing strain of the measles virus. Virus isolation and geno-
typing of measles virus to identify source of infection is
one of the strategies recommended by WHO AFRO to
achieve the measles elimination goal by 2020 [2].
The findings of our study are subjected to some limita-
tions. First, not all measles suspected cases, especially
during confirmed outbreaks, were reported through the
laboratory case-based surveillance data. Only three la-
boratory confirmed measles were enough to declare a
measles outbreak in that district; after that no additional
samples are collected for the next one month in that dis-
trict. Secondly, our results may not be representative of
all cases of measles and may be biased toward zones that
have a good surveillance system and populations with
more access to care. Finally, our analysis is limited by
the limited demographic and clinical information col-
lected on each reported case.
Conclusion and recommendation
In conclusion, the number and percentage of laboratory
confirmed measles cases are increasing from year to year
in the study area. Measles is widely circulating in the re-
gion primarily affecting age groups ≥10 years. We also
noted a seasonal peak during February-May. Based on
this finding, measles will remain a public health problem
in the Amhara Regional State of Ethiopia unless con-
certed efforts are made in the region and implemented
to increase the vaccination coverage and continuing sen-
sitive case based surveillance performance.
We also recommend conducting a wide age group vac-
cination campaign in the region as there is more case in
the age group >10 years. Additional study is needed in the
region to better understand the age shift, and the know-
ledge, attitude and practices of the general population and
health care professionals about measles infection and vac-
cination. As Ethiopia gets closer to measles elimination
targets, it will be important to introduce genotyping to de-
termine circulating measles virus strains.
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